Search

Author/Creator D'Amato, Gina

1. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021)

Authors:
Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz-Soto...
Journal:
Oncologist
Issue:
Volume 26:Number 11(2021)
Page Start:
e2053
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021)

Authors:
Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz‐Soto...
Journal:
Oncologist
Issue:
Volume 26:Number 11(2021)
Page Start:
e2053
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. Issue 15 (7th June 2019)

Authors:
Patel, Shreyaskumar; von Mehren, Margaret; Reed, Damon R.; Kaiser, Pamela; Charlson, John; Ryan, Christopher W.; Rushing, Daniel; Livingston, Michael; Singh, Arun; Seth, Rahul; Forscher, Charles; D'Amato, Gina; Chawla, Sant P.; McCarthy, Sharon; Wang, George; Parekh, Trilok; Knoblauch, Roland; He...
Journal:
Cancer
Issue:
Volume 125:Issue 15(2019)
Page Start:
2610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Issue 1 (3rd October 2016)

Authors:
Schuetze, Scott M.; Bolejack, Vanessa; Choy, Edwin; Ganjoo, Kristen N.; Staddon, Arthur P.; Chow, Warren A.; Tawbi, Hussein A.; Samuels, Brian L.; Patel, Shreyaskumar R.; von Mehren, Margaret; D'Amato, Gina; Leu, Kirsten M.; Loeb, David M.; Forscher, Charles A.; Milhem, Mohammed M.; Rushing, Dani...
Journal:
Cancer
Issue:
Volume 123:Issue 1(2017)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2020)

Authors:
Blay, Jean-Yves; Serrano, César; Heinrich, Michael C; Zalcberg, John; Bauer, Sebastian; Gelderblom, Hans; Schöffski, Patrick; Jones, Robin L; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Meade, Julie; Shi, Kelvin; Ruiz-Soto, Rodrigo; George, Suzanne; von Mehren, Margaret
Journal:
Lancet oncology
Issue:
Volume 21:Issue 7(2020)
Page Start:
923
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗